These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27841764)

  • 1. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells.
    Sherbenou DW; Aftab BT; Su Y; Behrens CR; Wiita A; Logan AC; Acosta-Alvear D; Hann BC; Walter P; Shuman MA; Wu X; Atkinson JP; Wolf JL; Martin TG; Liu B
    J Clin Invest; 2016 Dec; 126(12):4640-4653. PubMed ID: 27841764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.
    Su Y; Liu Y; Behrens CR; Bidlingmaier S; Lee NK; Aggarwal R; Sherbenou DW; Burlingame AL; Hann BC; Simko JP; Premasekharan G; Paris PL; Shuman MA; Seo Y; Small EJ; Liu B
    JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma.
    Sherbenou DW; Su Y; Behrens CR; Aftab BT; Perez de Acha O; Murnane M; Bearrows SC; Hann BC; Wolf JL; Martin TG; Liu B
    Clin Cancer Res; 2020 Nov; 26(22):6028-6038. PubMed ID: 32917735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells.
    Chen R; Rajan S; Overstreet MG; Hurt EM; Thomas SB; Muniz-Medina V; Ward C; Sadowska A; Fleming R; Karanth S; Breen S; Zheng B; Wu Y; Iverson WO; Novick S; O'Day T; Shah DP; Dimasi N; Tiberghien AC; Osbourn J; Walker J
    Mol Cancer Ther; 2020 Aug; 19(8):1649-1659. PubMed ID: 32404408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma.
    Elkins K; Zheng B; Go M; Slaga D; Du C; Scales SJ; Yu SF; McBride J; de Tute R; Rawstron A; Jack AS; Ebens A; Polson AG
    Mol Cancer Ther; 2012 Oct; 11(10):2222-32. PubMed ID: 22807577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 regulates CD46 expression and measles virus infection in myeloma cells.
    Lok A; Descamps G; Tessoulin B; Chiron D; Eveillard M; Godon C; Le Bris Y; Vabret A; Bellanger C; Maillet L; Barillé-Nion S; Gregoire M; Fonteneau JF; Le Gouill S; Moreau P; Tangy F; Amiot M; Moreau-Aubry A; Pellat-Deceunynck C
    Blood Adv; 2018 Dec; 2(23):3492-3505. PubMed ID: 30530776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma.
    Wadhwa A; Wang S; Patiño-Escobar B; Bidkar AP; Bobba KN; Chan E; Meher N; Bidlingmaier S; Su Y; Dhrona S; Geng H; Sarin V; VanBrocklin HF; Wilson DM; He J; Zhang L; Steri V; Wong SW; Martin TG; Seo Y; Liu B; Wiita AP; Flavell RR
    Clin Cancer Res; 2024 Mar; 30(5):1009-1021. PubMed ID: 38109209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma.
    Panowski SH; Kuo TC; Zhang Y; Chen A; Geng T; Aschenbrenner L; Kamperschroer C; Pascua E; Chen W; Delaria K; Farias S; Bateman M; Dushin RG; Chin SM; Van Blarcom TJ; Yeung YA; Lindquist KC; Chunyk AG; Kuang B; Han B; Mirsky M; Pardo I; Buetow B; Martin TG; Wolf JL; Shelton D; Rajpal A; Strop P; Chaparro-Riggers J; Sasu BJ
    Mol Cancer Ther; 2019 Nov; 18(11):2008-2020. PubMed ID: 31434693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates.
    Catcott KC; McShea MA; Bialucha CU; Miller KL; Hicks SW; Saxena P; Gesner TG; Woldegiorgis M; Lewis ME; Bai C; Fleming MS; Ettenberg SA; Erickson HK; Yoder NC
    MAbs; 2016; 8(3):513-23. PubMed ID: 26752675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD46-ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts.
    VanWyngarden MJ; Walker ZJ; Su Y; Perez de Acha O; Stevens BM; Forsberg PA; Mark TM; Matsui W; Liu B; Sherbenou DW
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.
    La Rocca F; Airoldi I; Di Carlo E; Marotta P; Falco G; Simeon V; Laurenzana I; Trino S; De Luca L; Todoerti K; Villani O; Lackmann M; D'Auria F; Frassoni F; Neri A; Del Vecchio L; Musto P; Cilloni D; Caivano A
    Cell Oncol (Dordr); 2017 Oct; 40(5):483-496. PubMed ID: 28721629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies.
    Deckert J; Wetzel MC; Bartle LM; Skaletskaya A; Goldmacher VS; Vallée F; Zhou-Liu Q; Ferrari P; Pouzieux S; Lahoute C; Dumontet C; Plesa A; Chiron M; Lejeune P; Chittenden T; Park PU; Blanc V
    Clin Cancer Res; 2014 Sep; 20(17):4574-83. PubMed ID: 24987056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.
    Moschetta M; Basile A; Ferrucci A; Frassanito MA; Rao L; Ria R; Solimando AG; Giuliani N; Boccarelli A; Fumarola F; Coluccia M; Rossini B; Ruggieri S; Nico B; Maiorano E; Ribatti D; Roccaro AM; Vacca A
    Clin Cancer Res; 2013 Aug; 19(16):4371-82. PubMed ID: 23804425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts.
    Koga Y; Manabe S; Aihara Y; Sato R; Tsumura R; Iwafuji H; Furuya F; Fuchigami H; Fujiwara Y; Hisada Y; Yamamoto Y; Yasunaga M; Matsumura Y
    Int J Cancer; 2015 Sep; 137(6):1457-66. PubMed ID: 25704403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate.
    Herbener P; Schönfeld K; König M; Germer M; Przyborski JM; Bernöster K; Schüttrumpf J
    PLoS One; 2018; 13(4):e0195823. PubMed ID: 29672587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
    Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Antitumor Activity of an Anti-5T4 Antibody-Drug Conjugate in Combination with PI3K/mTOR inhibitors or Taxanes.
    Shor B; Kahler J; Dougher M; Xu J; Mack M; Rosfjord E; Wang F; Melamud E; Sapra P
    Clin Cancer Res; 2016 Jan; 22(2):383-94. PubMed ID: 26319086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of chromosome arm 1q in patients in relapse and progression of multiple myeloma.
    Balcárková J; Urbánková H; Scudla V; Holzerová M; Bacovský J; Indrák K; Jarosová M
    Cancer Genet Cytogenet; 2009 Jul; 192(2):68-72. PubMed ID: 19596256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Antibody-Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies.
    Asundi J; Crocker L; Tremayne J; Chang P; Sakanaka C; Tanguay J; Spencer S; Chalasani S; Luis E; Gascoigne K; Desai R; Raja R; Friedman BA; Haverty PM; Polakis P; Firestein R
    Clin Cancer Res; 2015 Jul; 21(14):3252-62. PubMed ID: 25862760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma.
    Lee L; Bounds D; Paterson J; Herledan G; Sully K; Seestaller-Wehr LM; Fieles WE; Tunstead J; McCahon L; Germaschewski FM; Mayes PA; Craigen JL; Rodriguez-Justo M; Yong KL
    Br J Haematol; 2016 Sep; 174(6):911-22. PubMed ID: 27313079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.